510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K162167Substantially Equivalent

Caphosol Artifical Saliva Tablets

Eusa Pharma (Uk) Limited, Hemel Hempstead, GB / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K162167 is the FDA 510(k) clearance record for Caphosol Artifical Saliva Tablets, cleared for Eusa Pharma (Uk) Limited on under FDA product code LFD (Saliva, Artificial). FDA records list 2 510(k) clearances for Eusa Pharma (Uk) Limited, from to . As of , FDA records show no recalls naming K162167.

Clearance record

Decision date
Received
(240 days to decision)
Product code
LFD Saliva, Artificial
Device class
Unclassified
Review panel
Unknown
Applicant
Eusa Pharma (Uk) Limited Breakspear Park, Breakspear Way, Hemel Hempstead, GB
510(k) summary
Summary PDF
Third party review
No

Clearances, product code LFD

Trailing 12 months
1 clearance under product code LFD in the twelve months to October 2026, February 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code LFD, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20261
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260